Work

A Phase II Study Of V-BEAM (Bortezomib, Carmustine, Etoposide, Cytarabine, and Melphalan) As Conditioning Regimen Prior To Second Autologous Stem Cell Transplantation For Multiple Myeloma

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.5492.5492

Authors: Tzu-Fei Wang, Mark A. Fiala, Ningying Wu, Theresa Fletcher, Camille N. Abboud, Amanda F. Cashen, John F. Dipersio, Geoffrey L. Uy, Peter Westervelt, Keith E. Stockerl-Goldstein, Ravi Vij

Institutions: The Ohio State University, Washington University in St. Louis

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2554863886

FWCI: 0.475

Cites:

Cited by: 4

Related to: 10